Nanobiotix (NBTX) Accounts Payables: 2019-2024

Historic Accounts Payables for Nanobiotix (NBTX) over the last 5 years, with Dec 2024 value amounting to $21.4 million.

  • Nanobiotix's Accounts Payables fell 36.08% to $13.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.2 million, marking a year-over-year decrease of 36.08%. This contributed to the annual value of $21.4 million for FY2024, which is 8.53% up from last year.
  • Nanobiotix's Accounts Payables amounted to $21.4 million in FY2024, which was up 8.53% from $19.7 million recorded in FY2023.
  • In the past 5 years, Nanobiotix's Accounts Payables registered a high of $21.4 million during FY2024, and its lowest value of $7.7 million during FY2021.
  • For the 2-year period, Nanobiotix's Accounts Payables averaged around $20.6 million, with its median value being $20.6 million (2023).
  • As far as peak fluctuations go, Nanobiotix's Accounts Payables decreased by 6.76% in 2020, and later rose by 8.53% in 2024.
  • Nanobiotix's Accounts Payables (Yearly) stood at $8.1 million in 2020, then fell by 5.46% to $7.7 million in 2021, then reached $19.7 million in 2023, then rose by 8.53% to $21.4 million in 2024.